Silicon Laboratories SLAB AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss

AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss at other companies

AssurantAIZ

——

Revenue$213.5M+20.1%

Gross profit$127.0M+29.9%

Operating income-$17.1M+46.8%

Net income-$15.9M+47.8%

EPS (diluted)-$0.48+48.9%

Cash & equivalents$383.1M+17.9%

Total debt$24.0M+11.8%

Total equity$1.1B+2.8%

Total assets$1.3B+3.0%

Operating cash flow$4.9M-89.7%

CapEx$9.8M+103%

Free cash flow-$4.9M-111%

Market cap$7.25B+113%

P/S8.8×+3.6×

Gross margin59.3%+5.1pp

Operating margin-6.8%-2.7pp

Net margin-6.1%-2.6pp

FCF margin-6.3%-21.8pp

Return on equity-4.6%-1.9pp

Debt / equity0×0.0×

Current ratio5.1×-0.1×

Reported directly by Silicon Laboratories in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.

The official record: Silicon Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Silicon Laboratories's AFS and trading securities - unrealized loss position (>=12 months) accumulated loss?: Silicon Laboratories (SLAB) reported AFS and trading securities - unrealized loss position (>=12 months) accumulated loss of $0 in Q1 2026.
How has Silicon Laboratories's AFS and trading securities - unrealized loss position (>=12 months) accumulated loss changed year-over-year?: Silicon Laboratories's AFS and trading securities - unrealized loss position (>=12 months) accumulated loss decreased by 100.0% year-over-year, from $5K to $0.